Healthpeak Boosts 2026 Guidance After $1 Billion Brookfield Joint Venture — Healthpeak Properties, Inc.

Event summary

Healthpeak reported Q2 2026 net income of $0.08 per share and FFO as Adjusted of $0.46 per share.
The company closed a $1.025 billion joint venture with Brookfield for an outpatient medical portfolio valued at $2.1 billion.
Total occupancy increased sequentially by +20 bps in Outpatient Medical to 90.7% and by +80 bps in Lab to 78.5%.
Healthpeak generated $1.4 billion of proceeds from recapitalizations, loan repayments, and dispositions during Q2.
The company authorized a new $500 million share repurchase program.

The big picture

Healthpeak's strategic focus on healthcare real estate is underscored by the Brookfield joint venture, which highlights the company's ability to monetize high-value assets while maintaining control. The transaction reflects broader industry trends of consolidation and capital recycling in the healthcare property sector. With $3.4 billion in liquidity as of August 2026, Healthpeak is well-positioned to navigate market dynamics and pursue further investment opportunities.

What we're watching

Capital Allocation Strategy: How Healthpeak will deploy the $1.025 billion proceeds from the Brookfield joint venture to strengthen its balance sheet and fund future growth.
Occupancy Trends: Whether the sequential increases in occupancy rates for Outpatient Medical and Lab properties can be sustained amid broader market conditions.
Shareholder Returns: The pace at which Healthpeak will execute its new $500 million share repurchase program and its impact on stock price.